Selected research
Industry Research
Pre-Pregnancy Genetic Screening Service Industry Research Report 2026
Market perspective
The global Pre-Pregnancy Genetic Screening Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pre-Pregnancy Genetic Screening Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pre-Pregnancy Genetic Screening Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pre-Pregnancy Genetic Screening Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pre-Pregnancy Genetic Screening Service include Invitae, Natera, Fulgent Genetics, Myriad Genetics, Quest Diagnostics, LabCorp, GeneDx, Vitrolife and Illumina, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pre-Pregnancy Genetic Screening Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pre-Pregnancy Genetic Screening Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pre-Pregnancy Genetic Screening Service Market by Company
Invitae
Natera
Fulgent Genetics
Myriad Genetics
Quest Diagnostics
LabCorp
GeneDx
Vitrolife
Illumina
BillionToOne
Juno Genetics
MedGenome
23andMe
Sonic Genetics
CEN4GEN
BGI Genomics
Berry Genomics
Anoroad
KingMed Diagnostics
CapitalBio Technology
Pre-Pregnancy Genetic Screening Service Segment by Type
Single Disease Screening
Whole Genome Screening
Pre-Pregnancy Genetic Screening Service Segment by Application
Medical and Health Institutions
Research and Educational Institutions
Others
Pre-Pregnancy Genetic Screening Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pre-Pregnancy Genetic Screening Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pre-Pregnancy Genetic Screening Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pre-Pregnancy Genetic Screening Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pre-Pregnancy Genetic Screening Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Single Disease Screening
- Whole Genome Screening
Applications
- Medical and Health Institutions
- Research and Educational Institutions
- Others
Companies covered
- Invitae
- Natera
- Fulgent Genetics
- Myriad Genetics
- Quest Diagnostics
- LabCorp
- GeneDx
- Vitrolife
- Illumina
- BillionToOne
- Juno Genetics
- MedGenome
- 23andMe
- Sonic Genetics
- CEN4GEN
- BGI Genomics
- Berry Genomics
- Anoroad
- KingMed Diagnostics
- CapitalBio Technology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pre-Pregnancy Genetic Screening Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Single Disease Screening
- 2.2.3 Whole Genome Screening
- 2.3 Pre-Pregnancy Genetic Screening Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Medical and Health Institutions
- 2.3.3 Research and Educational Institutions
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Pre-Pregnancy Genetic Screening Service Breakdown Data by Type
- 3.1 Global Pre-Pregnancy Genetic Screening Service Historic Market Size by Type (2021-2026)
- 3.2 Global Pre-Pregnancy Genetic Screening Service Forecasted Market Size by Type (2027-2032)
4 Pre-Pregnancy Genetic Screening Service Breakdown Data by Application
- 4.1 Global Pre-Pregnancy Genetic Screening Service Historic Market Size by Application (2021-2026)
- 4.2 Global Pre-Pregnancy Genetic Screening Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pre-Pregnancy Genetic Screening Service Market Perspective (2021-2032)
- 5.2 Global Pre-Pregnancy Genetic Screening Service Growth Trends by Region
- 5.2.1 Global Pre-Pregnancy Genetic Screening Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pre-Pregnancy Genetic Screening Service Historic Market Size by Region (2021-2026)
- 5.2.3 Pre-Pregnancy Genetic Screening Service Forecasted Market Size by Region (2027-2032)
- 5.3 Pre-Pregnancy Genetic Screening Service Market Dynamics
- 5.3.1 Pre-Pregnancy Genetic Screening Service Industry Trends
- 5.3.2 Pre-Pregnancy Genetic Screening Service Market Drivers
- 5.3.3 Pre-Pregnancy Genetic Screening Service Market Challenges
- 5.3.4 Pre-Pregnancy Genetic Screening Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pre-Pregnancy Genetic Screening Service Players by Revenue
- 6.1.1 Global Top Pre-Pregnancy Genetic Screening Service Players by Revenue (2021-2026)
- 6.1.2 Global Pre-Pregnancy Genetic Screening Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Pre-Pregnancy Genetic Screening Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pre-Pregnancy Genetic Screening Service Head Office and Area Served
- 6.4 Global Pre-Pregnancy Genetic Screening Service Players, Product Type & Application
- 6.5 Global Pre-Pregnancy Genetic Screening Service Manufacturers Established Date
- 6.6 Global Pre-Pregnancy Genetic Screening Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pre-Pregnancy Genetic Screening Service Market Size (2021-2032)
- 7.2 North America Pre-Pregnancy Genetic Screening Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pre-Pregnancy Genetic Screening Service Market Size by Country (2021-2026)
- 7.4 North America Pre-Pregnancy Genetic Screening Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pre-Pregnancy Genetic Screening Service Market Size (2021-2032)
- 8.2 Europe Pre-Pregnancy Genetic Screening Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pre-Pregnancy Genetic Screening Service Market Size by Country (2021-2026)
- 8.4 Europe Pre-Pregnancy Genetic Screening Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pre-Pregnancy Genetic Screening Service Market Size (2021-2032)
- 9.2 Asia-Pacific Pre-Pregnancy Genetic Screening Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pre-Pregnancy Genetic Screening Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pre-Pregnancy Genetic Screening Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pre-Pregnancy Genetic Screening Service Market Size (2021-2032)
- 10.2 South America Pre-Pregnancy Genetic Screening Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pre-Pregnancy Genetic Screening Service Market Size by Country (2021-2026)
- 10.4 South America Pre-Pregnancy Genetic Screening Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pre-Pregnancy Genetic Screening Service Market Size (2021-2032)
- 11.2 Middle East & Africa Pre-Pregnancy Genetic Screening Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pre-Pregnancy Genetic Screening Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pre-Pregnancy Genetic Screening Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Invitae
- 12.1.1 Invitae Company Information
- 12.1.2 Invitae Business Overview
- 12.1.3 Invitae Revenue in Pre-Pregnancy Genetic Screening Service Business (2021-2026)
- 12.1.4 Invitae Pre-Pregnancy Genetic Screening Service Product Portfolio
- 12.1.5 Invitae Recent Developments
- 12.2 Natera
- 12.2.1 Natera Company Information
- 12.2.2 Natera Business Overview
- 12.2.3 Natera Revenue in Pre-Pregnancy Genetic Screening Service Business (2021-2026)
- 12.2.4 Natera Pre-Pregnancy Genetic Screening Service Product Portfolio
- 12.2.5 Natera Recent Developments
- 12.3 Fulgent Genetics
- 12.3.1 Fulgent Genetics Company Information
- 12.3.2 Fulgent Genetics Business Overview
- 12.3.3 Fulgent Genetics Revenue in Pre-Pregnancy Genetic Screening Service Business (2021-2026)
- 12.3.4 Fulgent Genetics Pre-Pregnancy Genetic Screening Service Product Portfolio
- 12.3.5 Fulgent Genetics Recent Developments
- 12.4 Myriad Genetics
- 12.4.1 Myriad Genetics Company Information
- 12.4.2 Myriad Genetics Business Overview
- 12.4.3 Myriad Genetics Revenue in Pre-Pregnancy Genetic Screening Service Business (2021-2026)
- 12.4.4 Myriad Genetics Pre-Pregnancy Genetic Screening Service Product Portfolio
- 12.4.5 Myriad Genetics Recent Developments
- 12.5 Quest Diagnostics
- 12.5.1 Quest Diagnostics Company Information
- 12.5.2 Quest Diagnostics Business Overview
- 12.5.3 Quest Diagnostics Revenue in Pre-Pregnancy Genetic Screening Service Business (2021-2026)
- 12.5.4 Quest Diagnostics Pre-Pregnancy Genetic Screening Service Product Portfolio
- 12.5.5 Quest Diagnostics Recent Developments
- 12.6 LabCorp
- 12.6.1 LabCorp Company Information
- 12.6.2 LabCorp Business Overview
- 12.6.3 LabCorp Revenue in Pre-Pregnancy Genetic Screening Service Business (2021-2026)
- 12.6.4 LabCorp Pre-Pregnancy Genetic Screening Service Product Portfolio
- 12.6.5 LabCorp Recent Developments
- 12.7 GeneDx
- 12.7.1 GeneDx Company Information
- 12.7.2 GeneDx Business Overview
- 12.7.3 GeneDx Revenue in Pre-Pregnancy Genetic Screening Service Business (2021-2026)
- 12.7.4 GeneDx Pre-Pregnancy Genetic Screening Service Product Portfolio
- 12.7.5 GeneDx Recent Developments
- 12.8 Vitrolife
- 12.8.1 Vitrolife Company Information
- 12.8.2 Vitrolife Business Overview
- 12.8.3 Vitrolife Revenue in Pre-Pregnancy Genetic Screening Service Business (2021-2026)
- 12.8.4 Vitrolife Pre-Pregnancy Genetic Screening Service Product Portfolio
- 12.8.5 Vitrolife Recent Developments
- 12.9 Illumina
- 12.9.1 Illumina Company Information
- 12.9.2 Illumina Business Overview
- 12.9.3 Illumina Revenue in Pre-Pregnancy Genetic Screening Service Business (2021-2026)
- 12.9.4 Illumina Pre-Pregnancy Genetic Screening Service Product Portfolio
- 12.9.5 Illumina Recent Developments
- 12.10 BillionToOne
- 12.10.1 BillionToOne Company Information
- 12.10.2 BillionToOne Business Overview
- 12.10.3 BillionToOne Revenue in Pre-Pregnancy Genetic Screening Service Business (2021-2026)
- 12.10.4 BillionToOne Pre-Pregnancy Genetic Screening Service Product Portfolio
- 12.10.5 BillionToOne Recent Developments
- 12.11 Juno Genetics
- 12.11.1 Juno Genetics Company Information
- 12.11.2 Juno Genetics Business Overview
- 12.11.3 Juno Genetics Revenue in Pre-Pregnancy Genetic Screening Service Business (2021-2026)
- 12.11.4 Juno Genetics Pre-Pregnancy Genetic Screening Service Product Portfolio
- 12.11.5 Juno Genetics Recent Developments
- 12.12 MedGenome
- 12.12.1 MedGenome Company Information
- 12.12.2 MedGenome Business Overview
- 12.12.3 MedGenome Revenue in Pre-Pregnancy Genetic Screening Service Business (2021-2026)
- 12.12.4 MedGenome Pre-Pregnancy Genetic Screening Service Product Portfolio
- 12.12.5 MedGenome Recent Developments
- 12.13 23andMe
- 12.13.1 23andMe Company Information
- 12.13.2 23andMe Business Overview
- 12.13.3 23andMe Revenue in Pre-Pregnancy Genetic Screening Service Business (2021-2026)
- 12.13.4 23andMe Pre-Pregnancy Genetic Screening Service Product Portfolio
- 12.13.5 23andMe Recent Developments
- 12.14 Sonic Genetics
- 12.14.1 Sonic Genetics Company Information
- 12.14.2 Sonic Genetics Business Overview
- 12.14.3 Sonic Genetics Revenue in Pre-Pregnancy Genetic Screening Service Business (2021-2026)
- 12.14.4 Sonic Genetics Pre-Pregnancy Genetic Screening Service Product Portfolio
- 12.14.5 Sonic Genetics Recent Developments
- 12.15 CEN4GEN
- 12.15.1 CEN4GEN Company Information
- 12.15.2 CEN4GEN Business Overview
- 12.15.3 CEN4GEN Revenue in Pre-Pregnancy Genetic Screening Service Business (2021-2026)
- 12.15.4 CEN4GEN Pre-Pregnancy Genetic Screening Service Product Portfolio
- 12.15.5 CEN4GEN Recent Developments
- 12.16 BGI Genomics
- 12.16.1 BGI Genomics Company Information
- 12.16.2 BGI Genomics Business Overview
- 12.16.3 BGI Genomics Revenue in Pre-Pregnancy Genetic Screening Service Business (2021-2026)
- 12.16.4 BGI Genomics Pre-Pregnancy Genetic Screening Service Product Portfolio
- 12.16.5 BGI Genomics Recent Developments
- 12.17 Berry Genomics
- 12.17.1 Berry Genomics Company Information
- 12.17.2 Berry Genomics Business Overview
- 12.17.3 Berry Genomics Revenue in Pre-Pregnancy Genetic Screening Service Business (2021-2026)
- 12.17.4 Berry Genomics Pre-Pregnancy Genetic Screening Service Product Portfolio
- 12.17.5 Berry Genomics Recent Developments
- 12.18 Anoroad
- 12.18.1 Anoroad Company Information
- 12.18.2 Anoroad Business Overview
- 12.18.3 Anoroad Revenue in Pre-Pregnancy Genetic Screening Service Business (2021-2026)
- 12.18.4 Anoroad Pre-Pregnancy Genetic Screening Service Product Portfolio
- 12.18.5 Anoroad Recent Developments
- 12.19 KingMed Diagnostics
- 12.19.1 KingMed Diagnostics Company Information
- 12.19.2 KingMed Diagnostics Business Overview
- 12.19.3 KingMed Diagnostics Revenue in Pre-Pregnancy Genetic Screening Service Business (2021-2026)
- 12.19.4 KingMed Diagnostics Pre-Pregnancy Genetic Screening Service Product Portfolio
- 12.19.5 KingMed Diagnostics Recent Developments
- 12.20 CapitalBio Technology
- 12.20.1 CapitalBio Technology Company Information
- 12.20.2 CapitalBio Technology Business Overview
- 12.20.3 CapitalBio Technology Revenue in Pre-Pregnancy Genetic Screening Service Business (2021-2026)
- 12.20.4 CapitalBio Technology Pre-Pregnancy Genetic Screening Service Product Portfolio
- 12.20.5 CapitalBio Technology Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst